-
Something wrong with this record ?
Protective Effect of Sulforaphane on Oxidative Stress and Mitochondrial Dysfunction Associated with Status Epilepticus in Immature Rats
J. Folbergrová, P. Ješina, J. Otáhal
Language English Country United States
Document type Journal Article
NLK
ProQuest Central
from 1997-02-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2010-02-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-02-01 to 1 year ago
Psychology Database (ProQuest)
from 1997-02-01 to 1 year ago
- MeSH
- NF-E2-Related Factor 2 * metabolism MeSH
- Isothiocyanates pharmacology MeSH
- Kelch-Like ECH-Associated Protein 1 metabolism MeSH
- Rats MeSH
- Mitochondria metabolism MeSH
- Oxidative Stress MeSH
- Status Epilepticus * metabolism MeSH
- Sulfoxides metabolism pharmacology MeSH
- Superoxides metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
The present study aimed to elucidate the effect of sulforaphane (a natural isothiocyanate) on oxidative stress and mitochondrial dysfunction during and at selected periods following status epilepticus (SE) induced in immature 12-day-old rats by Li-pilocarpine. Dihydroethidium was employed for the detection of superoxide anions, immunoblot analyses for 3-nitrotyrosine (3-NT) and 4-hydroxynonenal (4-HNE) levels and respiratory chain complex I activity for evaluation of mitochondrial function. Sulforaphane was given i.p. in two doses (5 mg/kg each), at PD 10 and PD 11, respectively. The findings of the present study indicate that both the acute phase of SE and the early period of epileptogenesis (1 week and 3 weeks following SE induction) are associated with oxidative stress (documented by the enhanced superoxide anion production and the increased levels of 3-NT and 4-HNE) and the persisting deficiency of complex I activity. Pretreatment with sulforaphane either completely prevented or significantly reduced markers of both oxidative stress and mitochondrial dysfunction. Since sulforaphane had no direct anti-seizure effect, the findings suggest that the ability of sulforaphane to activate Nrf2 is most likely responsible for the observed protective effect. Nrf2-ARE signaling pathway can be considered a promising target for novel therapies of epilepsy, particularly when new compounds, possessing inhibitory activity against protein-protein interaction between Nrf2 and its repressor protein Keap1, with less "off-target" effects and, importantly, with an optimal permeability and bioavailability properties, become available commercially.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003699
- 003
- CZ-PrNML
- 005
- 20230425140815.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12035-022-03201-x $2 doi
- 035 __
- $a (PubMed)36598650
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Folbergrová, Jaroslava $u Institute of Physiology of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague 4, Czech Republic. Jaroslava.folbergrova@fgu.cas.cz $1 https://orcid.org/0000000166977736 $7 jn20000400705
- 245 10
- $a Protective Effect of Sulforaphane on Oxidative Stress and Mitochondrial Dysfunction Associated with Status Epilepticus in Immature Rats / $c J. Folbergrová, P. Ješina, J. Otáhal
- 520 9_
- $a The present study aimed to elucidate the effect of sulforaphane (a natural isothiocyanate) on oxidative stress and mitochondrial dysfunction during and at selected periods following status epilepticus (SE) induced in immature 12-day-old rats by Li-pilocarpine. Dihydroethidium was employed for the detection of superoxide anions, immunoblot analyses for 3-nitrotyrosine (3-NT) and 4-hydroxynonenal (4-HNE) levels and respiratory chain complex I activity for evaluation of mitochondrial function. Sulforaphane was given i.p. in two doses (5 mg/kg each), at PD 10 and PD 11, respectively. The findings of the present study indicate that both the acute phase of SE and the early period of epileptogenesis (1 week and 3 weeks following SE induction) are associated with oxidative stress (documented by the enhanced superoxide anion production and the increased levels of 3-NT and 4-HNE) and the persisting deficiency of complex I activity. Pretreatment with sulforaphane either completely prevented or significantly reduced markers of both oxidative stress and mitochondrial dysfunction. Since sulforaphane had no direct anti-seizure effect, the findings suggest that the ability of sulforaphane to activate Nrf2 is most likely responsible for the observed protective effect. Nrf2-ARE signaling pathway can be considered a promising target for novel therapies of epilepsy, particularly when new compounds, possessing inhibitory activity against protein-protein interaction between Nrf2 and its repressor protein Keap1, with less "off-target" effects and, importantly, with an optimal permeability and bioavailability properties, become available commercially.
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a KEAP-1 $x metabolismus $7 D000072019
- 650 12
- $a faktor 2 související s NF-E2 $x metabolismus $7 D051267
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a isothiokyanatany $x farmakologie $7 D017879
- 650 _2
- $a sulfoxidy $x metabolismus $x farmakologie $7 D013454
- 650 12
- $a status epilepticus $x metabolismus $7 D013226
- 650 _2
- $a superoxidy $x metabolismus $7 D013481
- 650 _2
- $a mitochondrie $x metabolismus $7 D008928
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Ješina, Pavel $u Institute of Physiology of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague 4, Czech Republic
- 700 1_
- $a Otáhal, Jakub $u Institute of Physiology of the Czech Academy of Sciences, Vídeňská 1083, 142 20, Prague 4, Czech Republic
- 773 0_
- $w MED00005280 $t Molecular neurobiology $x 1559-1182 $g Roč. 60, č. 4 (2023), s. 2024-2035
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36598650 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425140812 $b ABA008
- 999 __
- $a ok $b bmc $g 1924395 $s 1189908
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 60 $c 4 $d 2024-2035 $e 20230104 $i 1559-1182 $m Molecular neurobiology $n Mol Neurobiol $x MED00005280
- LZP __
- $a Pubmed-20230418